ANDA 88793, held by Strides Pharma Intl. Disulfiram.
As of Nov 16, 2026, ANDA 88793 (Disulfiram), held by Strides Pharma Intl, was first approved by FDA on Aug 14, 1984, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 14, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Disulfiram500MG ยท tablet;oral | Disulfiram | Discontinued |
| Jun 4, 2009 | Supplement 9Labeling | Approved | None posted |
| Apr 3, 2009 | Supplement 8Labeling | Approved | None posted |
| Jan 10, 1989 | Supplement 7Labeling | Approved | None posted |
| Feb 10, 1987 | Supplement 2Manufacturing | Approved | None posted |
| Jan 9, 1987 | Supplement 4Manufacturing | Approved | None posted |
| Jan 9, 1987 | Supplement 3Manufacturing | Approved | None posted |
| Aug 14, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters